Description
Oxaliplatin is a third-generation, diaminocyclohexane-containing platinum anti-cancer drug. The anticancer activity and the antitumor specificity of oxaliplatin mainly depend on human organic cation transporters (OCT) 1 and OCT2.
Oxaliplatin is a third-generation, diaminocyclohexane-containing platinum anti-cancer drug. The anticancer activity and the antitumor specificity of oxaliplatin mainly depend on human organic cation transporters (OCT) 1 and OCT2.
Alternate Name/Synonyms: Foloxatine, Transplatin, Eloxatin, Eloxatine, Elplat, RP 54780, Dacplat, Oxalato(1R,2R-cyclohexanediamine)platinum(II), Oxalatoplatin, Oxalatoplatinum
Appearance: Off-white solid
Formulation: N/A
CAS Number: 61825-94-3
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₈H₁₄N₂O₄Pt
Molecular Weight: 397.29
Cell-Permeable?: Yes
Purity: ≥99%
Solubilities: DMSO
Handling: Protect from light and air
Country of Origin: USA
Tag Line: An anticancer agent
MDL Number: MFCD00866327
PubChem CID: 24197464
SMILES: C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+4]
InChi: InChI=1S/C6H14N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-6H,1-4,7-8H2;(H,3,4)(H,5,6);/q;;+4/p-2/t5-,6-;;/m1../s1
InChi Key: PCRKGXHIGVOZKB-BNTLRKBRSA-L
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
RT |
Shelf Life: |
24months |